Company:DEARhealth
| Type | Private |
|---|---|
| Industry | Healthcare |
| Founded | Los Angeles , California, United States (2013)[1] |
| Founder | Daniel Hommes Eric Esrailian[2] |
| Headquarters | Los Angeles , California; Amsterdam , United States, The Netherlands |
Key people | Daniel Hommes (co-Founder and CEO), Alberto Montilla (CTO), Aria Zand (CPO), Reender Beks (CFO), Katinka de Korte (General Manager Europe) |
| Website | dearhealth |
DEARhealth is a Dutch-American healthcare spin-out from the University of California, Los Angeles (UCLA), founded in 2013 by gastroenterologists Daniel Hommes and Eric Esrailian.
The company develops artificial intelligence-powered, personalized care pathways for chronic care.[3] The platform supports Value Based Health Care and aims to get the best outcomes for patients and providers, optimizing a value quotient (vQ), defined as patient value/provider costs.[4] Treatment areas include inflammatory bowel disease, pain management, liver diseases, ovarian cancer, chronic kidney diseases, low back pain and epilepsy.[5]
History
In 2012 DEARhealth started as a research project at UCLA. In 2013 DEARhealth was founded as a company. In June 2019 DEARhealth announced collaboration outside UCLA with UCB on epilepsy.[6] In July 2019, the company closed a series A funding round led by Philips.[7]
References
- ↑ "Bloomberg listing". Bloomberg. https://www.bloomberg.com/profile/company/1573188D:US.
- ↑ "Crunchbase listing". TechCrunch. https://www.crunchbase.com/organization/dearhealth.
- ↑ "Philips leads $6.8M funding round for AI-driven health tech startup". https://www.beckershospitalreview.com/artificial-intelligence/philips-leads-6-8m-funding-round-for-ai-driven-health-tech-startup.html.
- ↑ Esrailian, Eric; Hommes, Daniel W. (2015-03-01). "How Does a Gastroenterologist Show Value?" (in English). Clinical Gastroenterology and Hepatology 13 (3): 616–617. doi:10.1016/j.cgh.2014.10.024. ISSN 1542-3565. PMID 25445770. https://www.cghjournal.org/article/S1542-3565(14)01575-4/abstract.
- ↑ "Philips, Vesalius Biocapital III, Health Innovations invest in DEARhealth, AI health tech start-up". https://dearhealth.com/philips-vesalius-biocapital-health-innovations-fund-dearhealth-seriesa/.
- ↑ "UCB and Dearhealth Partner to Improve Care Coordination for Patients with Epilepsy" (in english). https://www.idigitalhealth.com/news/ucb-dearhealth-partner-to-improve-care-coordination-for-patients-with-epilepsy.
- ↑ "Philips, Vesalius Biocapital III, Health Innovations invest in DEARhealth, AI health tech start-up" (in en-US). https://www.marketwatch.com/press-release/philips-vesalius-biocapital-iii-health-innovations-invest-in-dearhealth-ai-health-tech-start-up-2019-07-18.
 |
